Protagonist Therapeutics Stock Price History
| PTGX Stock | USD 26.09 0.03 0.12% |
Below is the normalized historical share price chart for Protagonist Therapeutics extending back to August 11, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protagonist Therapeutics stands at 26.09, as last reported on the 7th of May, with the highest price reaching 26.59 and the lowest price hitting 25.75 during the day.
If you're considering investing in Protagonist Stock, it is important to understand the factors that can impact its price. We consider Protagonist Therapeutics very steady. Protagonist Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0292, which implies the firm had a 0.0292% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Protagonist Therapeutics, which you can use to evaluate the volatility of the company. Please check Protagonist Therapeutics' Semi Deviation of 2.58, coefficient of variation of 2809.96, and Risk Adjusted Performance of 0.0302 to confirm if the risk estimate we provide is consistent with the expected return of 0.0715%.
At this time, Protagonist Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 375.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 29.8 M in 2024. . At this time, Protagonist Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.39 in 2024, whereas Price To Sales Ratio is likely to drop 20.61 in 2024. Protagonist Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of August 2016 | 200 Day MA 21.901 | 50 Day MA 28.1264 | Beta 2.053 |
Protagonist |
Sharpe Ratio = 0.0292
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | PTGX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.45 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Protagonist Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protagonist Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.6803 | Enterprise Value Ebitda (13.67) | Price Sales 26.2626 | Shares Float 40.8 M | Wall Street Target Price 44.2 |
Protagonist Therapeutics Stock Price History Chart
There are several ways to analyze Protagonist Stock price data. The simplest method is using a basic Protagonist candlestick price chart, which shows Protagonist Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 1, 2024 | 32.15 |
| Lowest Price | April 25, 2024 | 24.66 |
Protagonist Therapeutics May 7, 2024 Stock Price Synopsis
Various analyses of Protagonist Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Protagonist Stock. It can be used to describe the percentage change in the price of Protagonist Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Protagonist Stock.| Protagonist Therapeutics Price Rate Of Daily Change | 1.00 | |
| Protagonist Therapeutics Price Action Indicator | (0.06) | |
| Protagonist Therapeutics Price Daily Balance Of Power | 0.04 |
Protagonist Therapeutics May 7, 2024 Stock Price Analysis
Protagonist Stock Price History Data
The price series of Protagonist Therapeutics for the period between Wed, Feb 7, 2024 and Tue, May 7, 2024 has a statistical range of 7.49 with a coefficient of variation of 6.55. The price distribution for the period has arithmetic mean of 27.82. The median price for the last 90 days is 28.0.| Open | High | Low | Close | Volume | ||
05/07/2024 | 26.20 | 26.59 | 25.75 | 26.09 | ||
| 05/06/2024 | 26.04 | 26.45 | 25.54 | 26.06 | 354,349 | |
| 05/03/2024 | 26.20 | 26.59 | 25.75 | 26.09 | 355,731 | |
| 05/02/2024 | 25.74 | 25.97 | 25.28 | 25.54 | 555,077 | |
| 05/01/2024 | 25.18 | 26.32 | 24.78 | 25.56 | 698,293 | |
| 04/30/2024 | 25.25 | 25.50 | 24.91 | 25.11 | 584,121 | |
| 04/29/2024 | 25.43 | 25.83 | 25.13 | 25.56 | 511,910 | |
| 04/26/2024 | 24.61 | 25.23 | 24.22 | 25.15 | 461,248 | |
| 04/25/2024 | 25.13 | 25.35 | 24.51 | 24.66 | 606,308 | |
| 04/24/2024 | 26.92 | 27.61 | 25.59 | 25.70 | 326,481 | |
| 04/23/2024 | 26.65 | 27.78 | 26.61 | 26.85 | 339,333 | |
| 04/22/2024 | 25.84 | 26.99 | 25.71 | 26.61 | 296,277 | |
| 04/19/2024 | 25.11 | 25.63 | 24.79 | 25.61 | 452,407 | |
| 04/18/2024 | 25.34 | 25.76 | 25.17 | 25.22 | 434,151 | |
| 04/17/2024 | 26.39 | 26.39 | 25.35 | 25.57 | 517,565 | |
| 04/16/2024 | 26.30 | 26.40 | 25.93 | 26.11 | 524,108 | |
| 04/15/2024 | 27.18 | 27.35 | 26.32 | 26.58 | 441,002 | |
| 04/12/2024 | 27.52 | 27.57 | 26.66 | 27.04 | 637,955 | |
| 04/11/2024 | 28.20 | 28.40 | 27.37 | 27.66 | 542,987 | |
| 04/10/2024 | 28.22 | 28.54 | 27.74 | 27.88 | 704,287 | |
| 04/09/2024 | 28.15 | 29.21 | 27.94 | 29.13 | 885,934 | |
| 04/08/2024 | 28.06 | 28.11 | 27.43 | 28.09 | 313,517 | |
| 04/05/2024 | 27.45 | 28.61 | 26.92 | 28.00 | 395,557 | |
| 04/04/2024 | 28.42 | 29.00 | 27.55 | 27.65 | 777,312 | |
| 04/03/2024 | 27.71 | 28.40 | 27.71 | 28.07 | 655,516 | |
| 04/02/2024 | 27.74 | 28.11 | 27.59 | 27.99 | 731,802 | |
| 04/01/2024 | 28.77 | 28.90 | 27.64 | 28.28 | 841,940 | |
| 03/28/2024 | 28.42 | 29.27 | 28.13 | 28.93 | 653,366 | |
| 03/27/2024 | 28.17 | 28.62 | 27.94 | 28.48 | 359,436 | |
| 03/26/2024 | 28.42 | 28.42 | 27.59 | 28.00 | 307,470 | |
| 03/25/2024 | 28.11 | 28.44 | 27.63 | 27.89 | 247,394 | |
| 03/22/2024 | 28.37 | 28.42 | 27.83 | 28.03 | 376,485 | |
| 03/21/2024 | 29.40 | 29.73 | 28.25 | 28.35 | 586,113 | |
| 03/20/2024 | 28.65 | 28.94 | 28.02 | 28.88 | 465,566 | |
| 03/19/2024 | 28.56 | 28.95 | 28.26 | 28.82 | 432,869 | |
| 03/18/2024 | 28.81 | 29.22 | 28.25 | 28.46 | 906,326 | |
| 03/15/2024 | 28.23 | 29.97 | 28.23 | 28.98 | 1,381,233 | |
| 03/14/2024 | 29.88 | 29.94 | 28.14 | 28.35 | 1,034,570 | |
| 03/13/2024 | 29.90 | 30.63 | 29.43 | 30.20 | 611,483 | |
| 03/12/2024 | 30.04 | 30.57 | 29.49 | 29.87 | 462,221 | |
| 03/11/2024 | 30.32 | 30.76 | 29.78 | 30.12 | 583,288 | |
| 03/08/2024 | 31.41 | 31.56 | 30.20 | 30.32 | 787,991 | |
| 03/07/2024 | 31.69 | 31.86 | 30.84 | 30.89 | 847,128 | |
| 03/06/2024 | 30.98 | 31.50 | 30.53 | 31.27 | 504,456 | |
| 03/05/2024 | 31.60 | 31.90 | 30.77 | 30.96 | 549,079 | |
| 03/04/2024 | 32.31 | 32.74 | 31.14 | 31.65 | 514,431 | |
| 03/01/2024 | 30.58 | 33.34 | 30.25 | 32.15 | 913,515 | |
| 02/29/2024 | 31.00 | 31.32 | 30.13 | 30.38 | 673,513 | |
| 02/28/2024 | 30.00 | 31.40 | 29.66 | 30.43 | 605,228 | |
| 02/27/2024 | 29.62 | 29.99 | 29.33 | 29.59 | 448,195 | |
| 02/26/2024 | 28.41 | 29.57 | 28.31 | 29.53 | 328,788 | |
| 02/23/2024 | 27.74 | 28.56 | 27.41 | 28.48 | 289,868 | |
| 02/22/2024 | 26.93 | 27.84 | 26.93 | 27.69 | 636,032 | |
| 02/21/2024 | 27.17 | 27.75 | 26.32 | 26.78 | 357,926 | |
| 02/20/2024 | 27.80 | 28.47 | 26.92 | 27.23 | 518,821 | |
| 02/16/2024 | 28.00 | 28.68 | 27.87 | 28.05 | 373,452 | |
| 02/15/2024 | 28.11 | 28.51 | 27.95 | 28.23 | 391,248 | |
| 02/14/2024 | 27.45 | 28.24 | 27.18 | 27.88 | 490,918 | |
| 02/13/2024 | 26.75 | 27.74 | 26.25 | 26.99 | 819,044 | |
| 02/12/2024 | 26.79 | 28.41 | 26.79 | 28.29 | 685,610 | |
| 02/09/2024 | 26.25 | 27.29 | 26.11 | 26.69 | 610,300 |
About Protagonist Therapeutics Stock history
Protagonist Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protagonist is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protagonist Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protagonist Therapeutics stock prices may prove useful in developing a viable investing in Protagonist Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56.8 M | 29.8 M | |
| Net Loss | -114.7 M | -108.9 M |
Protagonist Therapeutics Quarterly Net Working Capital |
|
Protagonist Therapeutics Stock Technical Analysis
Protagonist Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Protagonist Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protagonist Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protagonist Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protagonist to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0302 | |||
| Jensen Alpha | 0.0998 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0133 | |||
| Treynor Ratio | 10.46 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.Note that the Protagonist Therapeutics information on this page should be used as a complementary analysis to other Protagonist Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Protagonist Stock analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Protagonist Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagonist Therapeutics. If investors know Protagonist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagonist Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.057 | Quarterly Revenue Growth (1.00) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Protagonist Therapeutics is measured differently than its book value, which is the value of Protagonist that is recorded on the company's balance sheet. Investors also form their own opinion of Protagonist Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagonist Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagonist Therapeutics' market value can be influenced by many factors that don't directly affect Protagonist Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagonist Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagonist Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagonist Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.